Effect of Adherence to Home Spirometry on Bronchiolitis Obliterans and Graft Survival After Lung Transplantation

被引:34
作者
Kugler, Christiane [1 ]
Fuehner, Thomas [2 ]
Dierich, Martin [2 ]
DeWall, Claudia [2 ]
Haverich, Axel [1 ]
Simon, Andre [1 ]
Welte, Tobias [2 ]
Gottlieb, Jens [2 ]
机构
[1] Hannover Med Sch, Div Cardiac Thorac Transplantat & Vasc Surg, Hannover Thorac Transplant Program, D-30625 Hannover, Germany
[2] Hannover Med Sch, Div Resp Med, Hannover Thorac Transplant Program, D-30625 Hannover, Germany
关键词
Lung transplantation; Home spirometry; Nonadherence; Outcomes; PULMONARY-FUNCTION; MEDICAL REGIMEN; RISK-FACTORS; RELIABILITY; RECIPIENTS; REJECTION; VALIDITY; PROGRAM; SYSTEM;
D O I
10.1097/TP.0b013e3181aad129
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Patient-controlled home spirometry (HS) after lung transplantation has been shown to be valid and reliable to detect the presence of graft infection and rejection at its earliest onset. Effects of nonadherence to HS oil detection of the bronchiolitis obliterans syndrome (BOS) and on graft survival are unknown. Methods. A 7-year prospective cohort study assessed nonadherence longitudinally using electronic spirometry for 24 months. During follow-up, BOS, retransplantation, and survival were stratified by adherence groups. Results. Electronic monitoring of 226 patients confirmed that 123,487 measures were performed. Period prevalence was 0.76 measures per patient day and decreased significantly over time (P<0.0001). During follow-up, BOS was developed in 32% of patients; 5% received a second transplant, and mortality rate was 19%. Kaplan-Meier event-free analysis showed decreased freedom from BOS time in nonadherers (30%) compared with good (43%) or moderate adherers (19%) (log rank 6.008; P<0.014) and a tendency toward lower retransplantation rates (log rank 3.14; P<0.07). Mantel Cox regression revealed no impact of adherence on patient survival. Conclusions. This was the first study assessing nonadherence to HS based on electronic monitoring in relation to long-term outcome after lung transplantation. Nonadherers showed decreased freedom from BOS in the largest sample to date, but did not impact survival.
引用
收藏
页码:129 / 134
页数:6
相关论文
共 50 条
[41]   Cytomegalovirus Pneumonitis Is a Risk for Bronchiolitis Obliterans Syndrome in Lung Transplantation [J].
Snyder, Laurie D. ;
Finlen-Copeland, C. Ashley ;
Turbyfill, W. Jackson ;
Howell, David ;
Willner, Daniel A. ;
Palmer, Scott M. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181 (12) :1391-1396
[42]   Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis [J].
Gottlieb, J. ;
Mattner, F. ;
Weissbrodt, H. ;
Dierich, M. ;
Fuehner, T. ;
Strueber, M. ;
Simon, A. ;
Welte, T. .
RESPIRATORY MEDICINE, 2009, 103 (05) :743-749
[43]   Home Spirometry Telemonitoring for Early Detection of Bronchiolitis Obliterans Syndrome in Patients with Chronic Graft-versus-Host Disease [J].
Turner, Jane ;
He, Qianchuan ;
Baker, Kelsey ;
Chung, Lisa ;
Lazarevic-Fogelquist, Adrian ;
Bethune, Danika ;
Hubbard, Jesse ;
Guerriero, Margaret ;
Sheshadri, Ajay ;
Syrjala, Karen L. ;
Martin, Paul J. ;
Boeckh, Michael ;
Lee, Stephanie J. ;
Gooley, Ted ;
Flowers, Mary E. ;
Cheng, Guang-Shing .
TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (07) :616.e1-616.e6
[44]   Rescue alemtuzumab for refractory acute cellular rejection and bronchiolitis obliterans syndrome after lung transplantation [J].
Ensor, Christopher R. ;
Rihtarchik, Lindsey C. ;
Morrell, Matthew R. ;
Hayanga, J. W. Awori ;
Lichvar, Alicia B. ;
Pilewski, Joseph M. ;
Wisniewski, Stephen ;
Johnson, Bruce A. ;
D'Cunha, Jonathan ;
Zeevi, Adriana ;
McDyer, John F. .
CLINICAL TRANSPLANTATION, 2017, 31 (04)
[45]   Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis [J].
Kulkarni, Hrishikesh S. ;
Cherikh, Wida S. ;
Chambers, Daniel C. ;
Garcia, Victoria C. ;
Hachem, Ramsey R. ;
Kreisel, Daniel ;
Puri, Varun ;
Kozower, Benjamin D. ;
Byers, Derek E. ;
Witt, Chad A. ;
Alexander-Brett, Jennifer ;
Aguilar, Patrick R. ;
Tague, Laneshia K. ;
Furuya, Yuka ;
Patterson, G. Alec ;
Trulock, Elbert P., III ;
Yusen, Roger D. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (01) :5-16
[46]   Precision medicine: integration of genetics and functional genomics in prediction of bronchiolitis obliterans after lung transplantation [J].
Luijk, Bart ;
Vos, Robin ;
van Moorsel, Coline H. M. .
CURRENT OPINION IN PULMONARY MEDICINE, 2019, 25 (03) :308-316
[47]   A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy [J].
Vanaudenaerde, B. M. ;
Meyts, I. ;
Vos, R. ;
Geudens, N. ;
De Wever, W. ;
Verbeken, E. K. ;
Van Raemdonck, D. E. ;
Dupont, L. J. ;
Verleden, G. M. .
EUROPEAN RESPIRATORY JOURNAL, 2008, 32 (04) :832-843
[48]   Reliability of diagnostic criteria for bronchiolitis obliterans syndrome after lung transplantation: A survey [J].
Kapila, Atul ;
Baz, Maher A. ;
Valentine, Vincent G. ;
Bhorade, Sangeeta M. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (01) :65-74
[49]   Lung Histology Predicts Outcome of Bronchiolitis Obliterans Syndrome after Hematopoietic Stem Cell Transplantation [J].
Holbro, Andreas ;
Lehmann, Thomas ;
Girsberger, Sabine ;
Stern, Martin ;
Gambazzi, Franco ;
Lardinois, Didier ;
Heim, Dominik ;
Passweg, Jakob R. ;
Tichelli, Andre ;
Bubendorf, Lukas ;
Savic, Spasenija ;
Hostettler, Katrin ;
Grendelmeier, Peter ;
Halter, Joerg R. ;
Tamm, Michael .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (06) :973-980
[50]   Gene expression of profibrotic mediators in bronchiolitis obliterans syndrome after lung transplantation [J].
Bergmann, M ;
Tiroke, A ;
Schäfer, H ;
Barth, J ;
Haverich, A .
SCANDINAVIAN CARDIOVASCULAR JOURNAL, 1998, 32 (02) :97-103